GSK - BioSpace

NEWS

Business

Former GSK CEO Andrew Witty to Co-Lead WHO Vaccine Development Program

Sir Andrew Witty, the former head of GlaxoSmithKline, current president of UnitedHealth Group and chief executive officer of Optum, is temporarily stepping away from his duties to co-lead a World Health Organization effort to combat COVID-19.

April 15, 2020

2 min read

Alex Keown

BioCapital

WHO: More than 70 COVID-19 Vaccines are in Development, Three in Clinical Trials

It’s likely that more companies and universities will add additional assets as time goes on.

April 14, 2020

3 min read

Alex Keown

Drug Development

Biopharma Update on the Novel Coronavirus: April 14

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 14, 2020.

April 14, 2020

6 min read

BioSpace Editorial Staff

Business

GSK and Sanofi Join Forces to Develop a COVID-19 Vaccine

The two companies are eying the second half of this year to begin clinical trials on their combined project and, if the vaccine meets expectations, the companies said it could be available for use in the second half of 2021.

April 14, 2020

3 min read

Alex Keown

Policy

Biopharma Update on the Novel Coronavirus: April 8

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 8, 2020.

April 8, 2020

7 min read

BioSpace Editorial Staff

Policy

Biopharma Update on the Novel Coronavirus: April 7

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 7, 2020.

April 7, 2020

6 min read

BioSpace Editorial Staff

Business

GSK Strikes Deals with Vir Biotechnology and China’s Innovax Biotech Against COVID-19

Following close on the heels of its vaccine development agreement with China’s Xiamen Innovax Biotech, GlaxoSmithKline forged a research and development deal with Vir Biotechnology to develop treatments for COVID-19.

April 6, 2020

3 min read

Alex Keown